CSF diagnosis of Alzheimer’s disease and dementia with Lewy bodies
- 17 August 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neural Transmission
- Vol. 113 (11), 1771-1778
- https://doi.org/10.1007/s00702-006-0537-z
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier‐mediated epitope masking of amyloid β peptidesElectrophoresis, 2004
- CSF markers for Alzheimer's disease: Total tau, phospho-tau and Aβ42The World Journal of Biological Psychiatry, 2003
- Study of the Conformational Transition of Aβ(1−42) Using d-Amino Acid Replacement AnaloguesBiochemistry, 2001
- Tau and apo E in CSFNeuroReport, 1999
- Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's diseaseAnnals of Neurology, 1995
- Aggregation of Secreted Amyloid β-Protein into Sodium Dodecyl Sulfate-stable Oligomers in Cell CulturePublished by Elsevier BV ,1995
- A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal TauScience, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975